DESCRIPTION (provided by applicant): Calista Therapeutics has invented Calcaftor, a first-in-class peptide drug that can treat all Cystic Fibrosis (CF) patients. Calcaftor is validated in the gold sta ...SBIR Phase I 2014 Department of Health and Human Services
DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cy ...SBIR Phase I 2013 Department of Health and Human Services
CALISTA THERAPEUTICS, INC.
| 32 RIVERSIDE DR
LINCOLN, RI, 02865-1511
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||1|